Protein Phosphorylation in Cancer: Role of Nitric Oxide Signaling Pathway

Nitric oxide (NO), a free radical, plays a critical role in a wide range of physiological and pathological processes. Due to its pleiotropic function, it has been widely investigated in various types of cancers and is strongly associated with cancer development. Mounting pieces of evidence show that NO regulates various cancer-related events, which mainly depends on phosphorylating the key proteins in several signaling pathways. However, phosphorylation of proteins modulated by NO signaling pathway may lead to different effects in different types of cancer, which is complex and remains unclear. Therefore, in this review, we focus on the effect of protein phosphorylation modulated by NO signaling pathway in different types of cancers including breast cancer, lung cancer, prostate cancer, colon cancer, gastric cancer, pancreatic cancer, ovarian cancer, and neuroblastoma. Phosphorylation of key proteins, including p38 MAPK, ERK, PI3K, STAT3, and p53, modified by NO in various signaling pathways affects different cancer-related processes including cell apoptosis, proliferation, angiogenesis, metastasis, and several cancer therapies. Our review links the NO signaling pathway to protein phosphorylation in cancer development and provides new insight into potential targets and cancer therapy.

[1]  Huanghao Yang,et al.  Light-Switchable Yolk-Mesoporous Shell UCNPs@MgSiO3 for Nitric Oxide-Evoked Multidrug Resistance Reversal in Cancer Therapy. , 2020, ACS applied materials & interfaces.

[2]  K. Kashfi.  Nitric oxide in cancer and beyond. , 2020, Biochemical pharmacology.

[3]  D. Banerjee,et al.  Nitric Oxide and S-Nitrosylation in Cancers: Emphasis on Breast Cancer , 2020, Breast cancer : basic and clinical research.

[4]  Michal Wozniak,et al.  Nitric oxide and its derivatives in the cancer battlefield. , 2019, Nitric oxide : biology and chemistry.

[5]  M. Flint,et al.  Stress hormone-mediated acceleration of breast cancer metastasis is halted by inhibition of nitric oxide synthase. , 2019, Cancer letters.

[6]  A. Narayanankutty.  PI3K/ Akt/ mTOR pathway as a therapeutic target for colorectal cancer: A review of preclinical and clinical evidence. , 2019, Current drug targets.

[7]  Xiaoming Ma,et al.  Nitric Oxide Stimulated Programmable Drug Release of Nanosystem for Multidrug Resistance Cancer Therapy. , 2019, Nano letters.

[8]  A. I. Moretti,et al.  Nitric oxide and interactions with reactive oxygen species in the development of melanoma, breast, and colon cancer: A redox signaling perspective. , 2019, Nitric oxide : biology and chemistry.

[9]  A. Gamble,et al.  Controlled Delivery of Nitric Oxide for Cancer Therapy , 2019, Pharmaceutical nanotechnology.

[10]  Chulhong Kim,et al.  Tumor vasodilation by N-Heterocyclic carbene-based nitric oxide delivery triggered by high-intensity focused ultrasound and enhanced drug homing to tumor sites for anti-cancer therapy. , 2019, Biomaterials.

[11]  S. Lockwood,et al.  Ovarian Cancer: An Integrated Review. , 2019, Seminars in oncology nursing.

[12]  H. Xi,et al.  JS‐K induces reactive oxygen species‐dependent anti‐cancer effects by targeting mitochondria respiratory chain complexes in gastric cancer , 2019, Journal of cellular and molecular medicine.

[13]  E. Jeung,et al.  Nitric oxide prevents H2O2-induced apoptosis in SK-N-MC human neuroblastoma cells , 2018, International journal of biological sciences.

[14]  Wei Zhang,et al.  Biglycan, a Nitric Oxide-Downregulated Proteoglycan, Prevents Nitric Oxide-Induced Neuronal Cell Apoptosis via Targeting Erk1/2 and p38 Signaling Pathways , 2018, Journal of Molecular Neuroscience.

[15]  M. Sternak,et al.  Nitric oxide deficiency and endothelial–mesenchymal transition of pulmonary endothelium in the progression of 4T1 metastatic breast cancer in mice , 2018, Breast Cancer Research.

[16]  Y. Rojanasakul,et al.  Nitric oxide promotes cancer cell dedifferentiation by disrupting an Oct4:caveolin-1 complex: A new regulatory mechanism for cancer stem cell formation , 2018, The Journal of Biological Chemistry.

[17]  Q. Shen,et al.  The role of STAT3 in leading the crosstalk between human cancers and the immune system. , 2018, Cancer letters.

[18]  W. Andy Tao,et al.  Recent advances in phosphoproteomics and application to neurological diseases. , 2017, The Analyst.

[19]  Won Jong Kim,et al.  Combination of nitric oxide and drug delivery systems: tools for overcoming drug resistance in chemotherapy , 2017, Journal of controlled release : official journal of the Controlled Release Society.

[20]  BasudharDebashree,et al.  Nitric Oxide Synthase-2-Derived Nitric Oxide Drives Multiple Pathways of Breast Cancer Progression. , 2017 .

[21]  B. Rolando,et al.  Light-Regulated NO Release as a Novel Strategy To Overcome Doxorubicin Multidrug Resistance. , 2017, ACS medicinal chemistry letters.

[22]  R. Kumar,et al.  Phosphorylation: Implications in Cancer , 2017, The Protein Journal.

[23]  A. Schetter,et al.  Inducible nitric oxide synthase enhances disease aggressiveness in pancreatic cancer , 2016, Oncotarget.

[24]  R. Aebersold,et al.  On the Dependency of Cellular Protein Levels on mRNA Abundance , 2016, Cell.

[25]  De-Pei Liu,et al.  Netrin-1 suppresses the MEK/ERK pathway and ITGB4 in pancreatic cancer , 2016, Oncotarget.

[26]  Sean J. Humphrey,et al.  Protein Phosphorylation: A Major Switch Mechanism for Metabolic Regulation , 2015, Trends in Endocrinology & Metabolism.

[27]  A. Stern,et al.  Nitric oxide: Protein tyrosine phosphorylation and protein S-nitrosylation in cancer , 2015, Biomedical journal.

[28]  K. Kashfi,et al.  The dual role of iNOS in cancer☆ , 2015, Redox biology.

[29]  S. Huerta.  Nitric oxide for cancer therapy , 2015, Future science OA.

[30]  Xiaoyuan Yao,et al.  Nitric oxide/cyclic guanosine monophosphate inducers sodium nitroprusside and L-arginine inhibit the proliferation of gastric cancer cells via the activation of type II cyclic guanosine monophosphate-dependent protein kinase. , 2015, Oncology letters.

[31]  N. Hogg,et al.  Cancer cell metabolism and the modulating effects of nitric oxide. , 2015, Free radical biology & medicine.

[32]  H. Maeda,et al.  Poly-S-nitrosated human albumin enhances the antitumor and antimetastasis effect of bevacizumab, partly by inhibiting autophagy through the generation of nitric oxide , 2015, Cancer science.

[33]  Ke Huang,et al.  Arctigenin Promotes Apoptosis in Ovarian Cancer Cells via the iNOS/NO/STAT3/Survivin Signalling , 2014, Basic & clinical pharmacology & toxicology.

[34]  Shailendra Giri,et al.  Preclinical Therapeutic Potential of a Nitrosylating Agent in the Treatment of Ovarian Cancer , 2014, PloS one.

[35]  M. Brzezińska,et al.  Nitric oxide donors: spermine/NO and diethylenetriamine/NO induce ovarian cancer cell death and affect STAT3 and AKT signaling proteins. , 2013, Nitric oxide : biology and chemistry.

[36]  A. Gadbail,et al.  Nitric oxide and cancer: a review , 2013, World Journal of Surgical Oncology.

[37]  G. Chaudhuri,et al.  Mitochondrial-associated nitric oxide synthase activity inhibits cytochrome c oxidase: implications for breast cancer. , 2013, Free radical biology & medicine.

[38]  H. E. Marshall,et al.  S-nitrosylation of Ras in breast cancer , 2012, Breast Cancer Research.

[39]  S. Ambs,et al.  Nitric Oxide Synthase and Breast Cancer: Role of TIMP-1 in NO-mediated Akt Activation , 2012, PloS one.

[40]  Li Gao,et al.  Nitric oxide-donating aspirin induces G2/M phase cell cycle arrest in human cancer cells by regulating phase transition proteins. , 2012, International journal of oncology.

[41]  Li Gao,et al.  Abstract 3817: Nitric oxide-donating aspirin induces G2/M phase cell cycle arrest in human cancer cells by regulating phase transition proteins , 2012 .

[42]  S. Babykutty,et al.  Insidious role of nitric oxide in migration/invasion of colon cancer cells by upregulating MMP-2/9 via activation of cGMP-PKG-ERK signaling pathways , 2012, Clinical & Experimental Metastasis.

[43]  Yongchang Chen,et al.  Nitric oxide inhibits gastric cancer cell growth through the modulation of the Akt pathway. , 2011, Molecular medicine reports.

[44]  Myoung-Dong Kim,et al.  Sepiapterin inhibits cell proliferation and migration of ovarian cancer cells via down-regulation of p70S6K-dependent VEGFR-2 expression. , 2011, Oncology reports.

[45]  A. Baba,et al.  The specific Na+/Ca2+ exchange inhibitor SEA0400 prevents nitric oxide-induced cytotoxicity in SH-SY5Y cells , 2011, Neurochemistry International.

[46]  L. Dwyer-Nield,et al.  Regulation of cytokine-induced prostanoid and nitric oxide synthesis by extracellular signal–regulated kinase 1/2 in lung epithelial cells , 2010, Experimental lung research.

[47]  M. Hirota,et al.  Nitric Oxide Inhibits the Proliferation and Invasion of Pancreatic Cancer Cells through Degradation of Insulin Receptor Substrate-1 Protein , 2010, Molecular Cancer Research.

[48]  E. A. Fattah,et al.  Src Kinase-mediated Phosphorylation Stabilizes Inducible Nitric-oxide Synthase in Normal Cells and Cancer Cells* , 2009, The Journal of Biological Chemistry.

[49]  L. Dwyer-Nield,et al.  Growth Inhibition and Regression of Lung Tumors by Silibinin: Modulation of Angiogenesis by Macrophage-Associated Cytokines and Nuclear Factor-κB and Signal Transducers and Activators of Transcription 3 , 2009, Cancer Prevention Research.

[50]  H. Yasuda,et al.  Solid tumor physiology and hypoxia-induced chemo/radio-resistance: novel strategy for cancer therapy: nitric oxide donor as a therapeutic enhancer. , 2008, Nitric oxide : biology and chemistry.

[51]  S. Loibl,et al.  NO signaling confers cytoprotectivity through the survivin network in ovarian carcinomas. , 2008, Cancer research.

[52]  M. Nagarkatti,et al.  Nitric oxide inactivates the retinoblastoma pathway in chronic inflammation. , 2007, Cancer research.

[53]  S. Macdonald-Goodfellow,et al.  Chemosensitization of Cancer In vitro and In vivo by Nitric Oxide Signaling , 2007, Clinical Cancer Research.

[54]  P. Goswami,et al.  A redox cycle within the cell cycle: ring in the old with the new , 2007, Oncogene.

[55]  Yonghong Xiao,et al.  FoxOs Are Lineage-Restricted Redundant Tumor Suppressors and Regulate Endothelial Cell Homeostasis , 2007, Cell.

[56]  R. Jain,et al.  The role of nitric oxide in tumour progression , 2006, Nature Reviews Cancer.

[57]  Liying Wang,et al.  Nitric oxide regulates cell sensitivity to cisplatin-induced apoptosis through S-nitrosylation and inhibition of Bcl-2 ubiquitination. , 2006, Cancer research.

[58]  M. Fraser,et al.  Regulation of p53 and suppression of apoptosis by the soluble guanylyl cyclase/cGMP pathway in human ovarian cancer cells , 2006, Oncogene.

[59]  B. Rigas,et al.  Nitric Oxide-Donating Aspirin Inhibits Colon Cancer Cell Growth via Mitogen-Activated Protein Kinase Activation , 2006, Journal of Pharmacology and Experimental Therapeutics.

[60]  Hongying Wang,et al.  Overexpressed beta-catenin blocks nitric oxide-induced apoptosis in colonic cancer cells. , 2005, Cancer research.

[61]  E. Martinelli,et al.  Survivin expression in ovarian cancer and its correlation with clinico-pathological, surgical and apoptosis-related parameters , 2005, British Journal of Cancer.

[62]  Simon C Watkins,et al.  Nitric Oxide and Ionizing Radiation Synergistically Promote Apoptosis and Growth Inhibition of Cancer by Activating p53 , 2004, Cancer Research.

[63]  A. Porter,et al.  JNK-dependent Phosphorylation of c-Jun on Serine 63 Mediates Nitric Oxide-induced Apoptosis of Neuroblastoma Cells* , 2004, Journal of Biological Chemistry.

[64]  W. Freije,et al.  MKP-1-induced dephosphorylation of extracellular signal-regulated kinase is essential for triggering nitric oxide-induced apoptosis in human breast cancer cell lines: implications in breast cancer. , 2003, Cancer research.

[65]  G. Semenza.  Targeting HIF-1 for cancer therapy , 2003, Nature Reviews Cancer.

[66]  V. Steele,et al.  Is inducible nitric oxide synthase a target for chemoprevention? , 2003, Molecular cancer therapeutics.

[67]  T. Billiar,et al.  Nitric oxide prevents 6‐hydroxydopamine‐induced apoptosis in PC12 cells through cGMP‐dependent PI3 kinase/Akt activation , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[68]  L. Dwyer-Nield,et al.  Genetic ablation of inducible nitric oxide synthase decreases mouse lung tumorigenesis. , 2002, Cancer research.

[69]  J. K. Lee,et al.  Role of cyclooxygenase‐2 and inducible nitric oxide synthase in pancreatic cancer , 2002, Journal of gastroenterology and hepatology.

[70]  P. Phillips,et al.  Nitric oxide modulates capillary formation at the endothelial cell-tumor cell interface. , 2001, American journal of physiology. Lung cellular and molecular physiology.

[71]  Ö. Tulunay,et al.  Inducible nitric oxide synthase expression in benign prostatic hyperplasia, low‐ and high‐grade prostatic intraepithelial neoplasia and prostatic carcinoma , 2001, BJU international.

[72]  E. Wagner,et al.  Amino-terminal phosphorylation of c-Jun regulates stress-induced apoptosis and cellular proliferation , 1999, Nature Genetics.

[73]  J. Tainer,et al.  Structure of nitric oxide synthase oxygenase dimer with pterin and substrate. , 1998, Science.

[74]  Dai Fukumura,et al.  Role of nitric oxide in angiogenesis and microcirculation in tumors , 1998, Cancer and Metastasis Reviews.

[75]  M. Korc,et al.  Increased expression of insulin receptor substrate-1 in human pancreatic cancer. , 1996, Biochemical and biophysical research communications.

[76]  C. Harris,et al.  Nitric oxide-induced p53 accumulation and regulation of inducible nitric oxide synthase expression by wild-type p53. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[77]  F. Iavarone,et al.  Enrichments of post-translational modifications in proteomic studies. , 2019, Journal of separation science.

[78]  J. Ross,et al.  NO‐sulindac inhibits the hypoxia response of PC‐3 prostate cancer cells via the Akt signalling pathway , 2009, International journal of cancer.

[79]  Guoyao Wu,et al.  Nitric oxide in physiologic concentrations targets the translational machinery to increase the proliferation of human breast cancer cells: involvement of mammalian target of rapamycin/eIF4E pathway. , 2007, Cancer research.